MedTrace Logo

Influence of Obesity and Gastric Bypass on Medication Absorption

NCT01571180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-05-18

No results posted yet for this study

Summary

Patients who have scheduled a gastric bypass (RYGB) in UZ Leuven, will be questioned preoperatively and one, three, six and twelve months after gastric bypass surgery. The purpose of this study is to explore current practice regarding the use of medication and medication counseling after RYGB and to examine the changes in dietary pattern before and after RYGB.

Conditions

Sponsors & Collaborators

  • KU Leuven

    lead OTHER

Principal Investigators

  • Ina Gesquiere, PhD Student · Katholieke Universiteit Leuven - Centre for Pharmacotherapy

  • Veerle Foulon, Pharm PhD · Katholieke Universiteit Leuven - Centre for Pharmacotherapy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2017-08-31
Completion
2017-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01571180 on ClinicalTrials.gov